1. Introduction {#sec1-molecules-22-02252}
===============

Sesquiterpene lactones are the largest group of secondary metabolites, comprising more than 10,000 structures known up to now. They possess high structural diversity and are chemotaxonomic markers of the *Asteraceae* and *Compositae* families \[[@B1-molecules-22-02252]\]. Germacrene-type sesquiterpenoids possess a cyclodecadiene ring in their scaffold, and are considered key precursors in the biosynthesis of other natural sesquiterpenes. The two endocyclic double bonds, found in four possible geometrical isomers, are responsible for the high reactivity of the cyclodecadiene moiety, which undergoes cyclization even under mild conditions \[[@B2-molecules-22-02252]\]. Therefore, germacrenes are ideal starting points for diversity-oriented and biomimetic synthesis \[[@B3-molecules-22-02252],[@B4-molecules-22-02252],[@B5-molecules-22-02252],[@B6-molecules-22-02252]\]. It is well established that the outcome of the cyclization depends on the spatial rearrangement of the cyclodecadiene ring and, therefore, on the stereochemistry of the diene. We recently reported on the spontaneous rearrangement of nobilin **1**, an *E*,*Z*-germacranolide isolated from the flowers of Roman chamomile (*Anthemis nobilis*) in aqueous media under physiological conditions \[[@B7-molecules-22-02252]\]. We then investigated the rearrangement of **1** in aqueous and organic acidic media and found a transformation into various cadinane derivatives \[[@B8-molecules-22-02252]\]. In the present study we investigated the rearrangement of epoxy derivatives **2**--**4** of nobilin (**1**) under acidic conditions. We hypothesized that the presence of an epoxy group, acting as a conformational anchor, would strongly affect the outcome of the cyclization \[[@B9-molecules-22-02252]\]. This has previously been shown for parthenolide, the major sesquiterpene lactone in feverfew (*Parthenium integrifolium*), which undergoes transannular cyclization to a guianolide skeleton \[[@B10-molecules-22-02252],[@B11-molecules-22-02252],[@B12-molecules-22-02252]\]. We here compare the reactivity of nobilin (**1**) and of its epoxy derivatives **2** and **3** with that of parthenolide, and rationalize the outcome on the basis of conformational analysis and computational studies.

2. Results and Discussion {#sec2-molecules-22-02252}
=========================

2.1. Chemical Studies {#sec2dot1-molecules-22-02252}
---------------------

Nobilin **1** was isolated in large quantities from the *Anthemis nobilis* flower cones. Epoxides **2** and **3** were prepared according to reported procedures \[[@B13-molecules-22-02252]\]. Treatment of nobilin **1** with *meta*-chloroperoxybenzoic acid (*m*-CPBA) in dichlomethane afforded compounds **2**--**4** in a 10:1:0.5 ratio. Epoxide **2** showed identical spectroscopic data to those reported for the natural compound \[[@B14-molecules-22-02252]\]. Epoxide **3** was here obtained for the first time by the Sharpless epoxidation method ([Scheme 1](#molecules-22-02252-sch001){ref-type="scheme"}) \[[@B15-molecules-22-02252]\]. The *beta* stereochemistry of the 4,5-epoxy group of **3** was inferred via *J* couplings and NOEs. The ^3^*J* H-5/H-6 value of 9.7 Hz was indicative of the anti-diaxial orientation of H-5 and H-6, and key NOEs between H-6/H-8 and H-6/H~3~-14 supported the cofacial orientation of H-6, H-8, and H~3~-14. Similarly, key NOEs between H-5/H-7, H-5/H~3~-15, and H-1/H~3~-15 showed that H-7, H~3~-15, and H-1 were on the same molecular plane, in agreement with the optimized structure of **3**.

We began our study by treating compound **2** with *p*-toluensulfonic acid (*p*-TsOH·H~2~O), a mild acid that has been extensively used to induce transannular cyclization in germacradiene derivatives \[[@B8-molecules-22-02252],[@B16-molecules-22-02252]\]. After 1 h at room temperature, compound **5** (50%) and an inseparable mixture of **6** and **7** in a 3:2 ratio (10%) were obtained ([Scheme 2](#molecules-22-02252-sch002){ref-type="scheme"}). Compound **5** had the same molecular formula and degree of unsaturation as **2** (molecular ion at *m*/*z* 385.1632 \[M + Na\]^+^, calculated for C~20~H~26~NaO~6~: 385.1622) by analysis of its ^13^C-NMR and HRESIMS spectra. Analysis of COSY and HMBC spectra revealed that the fragment C4--C9 of **5** was as in the starting material. A significant downfield shift for C-1 and C-10 (δ~C~ = 77.6, C-1; δ~C~ = 87.3, C-10) compared to those in **2** (δ~C~ = 60.7, C-1; δ~C~ = 57.7, C-10) suggested that a rearrangement of the epoxy group has occurred, although both carbons still bore hydroxyl groups. The downfield shift of C-3 (δ~C~ = 81.7 in **5** vs. δ~C~ = 71.2 in **2**), along with the long-range HMBC correlation from H-3 to C-10, suggested the presence of an ether bridge between carbons C-3 and C-10. Hence, **5** was a furanoheliangolide. The beta stereochemistry of the epoxy bridge, inferred on the basis of geometrical and mechanistic considerations, was confirmed through key NOEs between H-1/H-3, H-3/H-6, H~3~-14/H-8, and H~3~-14/H-6 that were in agreement with the 3D structure of **5** ([Figures S22 and S23](#app1-molecules-22-02252){ref-type="app"}).

Compounds **6** and **7** were obtained as an inseparable mixture in a ratio of 3:1. For both compounds, a \[M + Na\]^+^ ion at *m*/*z* 385.1632 was observed, corresponding to a molecular formula of C~20~H~26~NaO~6~ (calculated for C~20~H~26~NaO~6~: 385.1622). Hence, the two molecules were isomers. Close inspection of the NMR data ([Table 1](#molecules-22-02252-t001){ref-type="table"} and [Table 2](#molecules-22-02252-t002){ref-type="table"}) revealed that in both compounds the methylene group at C-9 had been replaced by vinylic moieties (δ~H~ = 5.18 and 5.30 for **6** and **7**, respectively), thereby suggesting that the opening of the oxirane and subsequent formation of an allylic carbon had occurred. The differing chemical shifts of the vinylic protons were attributed to the *E*- and *Z*-stereochemistry of the newly formed double bond, respectively. The strong NOESY contact between H-9 and H-1 (δ~H~ = 5.18 and 4.05, respectively), and between H~3~-14 and H-6 (δ~H~ = 1.95 and 6.00, respectively), in the major isomer **6** of the mixture were in favor of a *trans*-oriented double bond. For the minor compound **7** of the mixture, a strong NOESY cross peak between H-9 and H~3~-14 (δ~H~ = 5.30 and 1.80, respectively) supported the *cis* configuration of the double bond at C-9/C-10 ([Figure S28](#app1-molecules-22-02252){ref-type="app"}). Interestingly, the C-1 epimer of compound **7** has recently been isolated from *Anthemis nobilis* \[[@B17-molecules-22-02252]\].

A similar rearrangement to a furanoheliangolide was observed after treatment of **2** with BF~3~·Et~2~O in anhydrous conditions, and **5** was obtained as the major reaction product (50%) ([Scheme 2](#molecules-22-02252-sch002){ref-type="scheme"}). Surprisingly, epoxy derivative **3** did not react under the above reaction conditions, as confirmed by TLC and NMR ([Figure S63](#app1-molecules-22-02252){ref-type="app"}).

For further confirmation of the higher reactivity of the 1,10-epoxyde compared to the 4,5-epoxide, the bisepoxy derivative **4** was submitted to the same acidic treatment ([Scheme 3](#molecules-22-02252-sch003){ref-type="scheme"}). Similar to **2**, treatment of **4** afforded C-3-C-10 furanoheliangolide derivatives **8**--**10**. In compound **8** (HRESIMS *m*/*z* 401.1591 \[M + Na\]^+^, calculated for C~20~H~26~NaO~7~ 401.1571), which was obtained as a major reaction product by treatment with both acid catalysts, the 4,5-epoxy group did not react. Conversely, the 4,5-epoxide underwent nucleophilic addition of the catalyst and elimination in compounds **9** and **10**, respectively.

Compound **9**, showed a molecular formula of C~27~H~34~O~10~S (HRESIMS *m*/*z* 573.1786 \[M + Na\]^+^, calculated for C~27~H~34~NaO~10~S: 573.1765). In the ^1^H-NMR spectrum, resonances characteristic of an AA′BB′ aromatic system were present (δ~H~ = 7.41 and 7.76 pseudo d, *J* = 8.3 Hz, 2 protons each), together with an additional methyl group attached to an aromatic ring (δ~H~ = 2.45, s, 3H). These spectroscopic data, together with the sulphonyl group indicated by the molecular formula, showed that the *p*-toluensulphonate group has reacted with **4**. The site of the nucleophilic attach was located at C-5, as indicated by the downfield shift of H-5 (δ~H~ = 4.79 and δ~C~ = 89.3 in **9** vs. δ~H~ = 2.85 and δ~C~ = 63.4 in **4**), while its orientation was established as *alpha* on the basis of the ^3^*J*H-5/H-6 value of ≤1 Hz.

Compound **10** showed a molecular formula of C~20~H~24~NaO~6~ (HRESIMS *m*/*z* 383.1500 \[M + Na\]^+^, calculated for C~20~H~24~NaO~6~: 383.1465) with nine degrees of hydrogen deficiency, which, compared to **4**, indicated the loss of an oxygen group and the formation of an additional double bond. The NMR data revealed diagnostic differences in comparison to **4**, including three olefinic protons in the low field region, two of which showed ^3^*J* coupling (δ~H~ = 5.48 dq, *J* = 5.8 and 1.2 Hz, δ~H~ = 5.89 d, *J* = 5.7 Hz, and δ~H~ = 6.22 d, *J* = 5.7 Hz), absence of oxygenated protons at C-1, C-3 and C-5, absence of the methylene group attached at C-2, and the presence of a quaternary carbon resonating at δ~C~ = 110.4, diagnostic of a hemiacetal group. The latter carbon resonance exhibited HMBC correlations with the ^3^*J* coupled olefin and the olefinic methyl group. All this spectroscopic evidence suggested that a dihydrofurane had been formed via elimination of the hydroxyl group at C-1, and that the 4(5)-epoxide had rearranged into an allylic hemiacetal. A speculative mechanism for the latter transformation would start with the opening of the 4,5-epoxy group at C-4, subsequent formation of an allylic alcohol (double bond between C-3 and C-4 and hydroxyl group at C-5), followed by transposition of the hydroxyl group to C-3 and of the double bond between C-4 and C-5 \[[@B18-molecules-22-02252],[@B19-molecules-22-02252]\]. The *cis* stereochemistry of the C-4/C-5 double bond was assigned via the key NOE between H-5 and H~3~-15. The 8-epimer of compound **10** has been previously isolated as a natural product from the sunflower cultivar cv. Peredovick \[[@B20-molecules-22-02252]\].

Given that the postulated reactivity of the 1(10)-epoxy group towards a transannular cyclization was precluded by the high reactivity of the hydroxyl group at C-3, we acetylated this moiety of epoxy derivatives **2** and **3** in order to prevent the formation of the furane ring and to facilitate a transannular cyclization.

The reaction of **11** with *p*-TsOH·H~2~O proceeded slowly and afforded compounds **13** and **14** in 10% and 5% yield, respectively ([Scheme 4](#molecules-22-02252-sch004){ref-type="scheme"}). Compound **13** (HRESIMS *m*/*z* 427.1749 \[M + Na\]^+^, calculated for C~22~H~28~NaO~7~: 427.1727) showed NMR data virtually superimposable to those of **6**, with the difference of an additional 3-acetoxy moiety. The compound was isolated in higher yield (40%) using BF~3~·Et~2~O as acid catalyst.

Compound **14** showed the same molecular formula as **13** and was a positional isomer of the latter. Compared to **13**, the NMR spectra indicated the absence of a methyl group at C-10 and of an olefinic proton at C-9, together with the appearance of an exocyclic methylene group (δ~H~ = 5.48 and 5.51, br s, δ~C~ = 116.5). Hence, the position of the unsaturation was at C-10/C-14.

As for **3**, derivative **12** was recovered unchanged after stirring at room temperature for 12 h in the presence of *p*-TsOH·H~2~O. Conversely, treatment of **12** with BF~3~·Et~2~O yielded cadinane acids **15** and **16**. Compound **15** showed a molecular formula of C~20~H~24~O~5~ (HRESIMS *m*/*z* 367.1530 \[M + Na\]^+^; calculated for C~20~H~24~NaO~5~: 367.1516). Close inspection of the NMR data revealed that **15** was the 3-hydroxy derivative of a cadinane that had been previously obtained by a reaction of nobilin with acids, whereby the transannular cyclization of the 1(10) double bond was facilitated by the alkyl--oxygen cleavage of the lactone ring. The reaction led to the formation of a single bond, C-5/C-10, which transformed the cyclodecadiene into a decaline ring system \[[@B7-molecules-22-02252],[@B8-molecules-22-02252]\].

Compound **16** had a molecular formula of C~15~H~14~O~2~ (HRESIMS *m*/*z* 249.0899 \[M + Na\]^+^, calculated for C~15~H~14~NaO~2~: 249.0886). Its ^1^H-NMR spectrum displayed resonances of seven olefinic protons and two methyl groups ([Table 3](#molecules-22-02252-t003){ref-type="table"} and [Table 4](#molecules-22-02252-t004){ref-type="table"}), indicative of the loss of the angelate and hydroxyl substituents, and the formation of a naphthalene ring bearing the acrylate group ([Scheme 4](#molecules-22-02252-sch004){ref-type="scheme"}).

2.2. Computational Studies {#sec2dot2-molecules-22-02252}
--------------------------

In order to rationalize the differing reactivity of epoxides **2** and **3** ([Figure 1](#molecules-22-02252-f001){ref-type="fig"} and [Figure 2](#molecules-22-02252-f002){ref-type="fig"}, respectively) and compare it with that of parthenolide ([Scheme 5](#molecules-22-02252-sch005){ref-type="scheme"}), we performed theoretical studies. The aim was to characterize, at the molecular level, transition states of intermediates and products and to predict reaction diagrams. Furthermore, we postulated the conversion of **3** into its corresponding micheliolide derivative following the same reaction pathway as reported for parthenolide [Figure 3](#molecules-22-02252-f003){ref-type="fig"}.

Prior to reaction calculations, an exhaustive conformational analysis of **2**, **3**, and parthenolide was carried out, followed by optimization of the most stable conformer by density functional calculation at the B3LYP/6-31+G(d,p) level \[[@B21-molecules-22-02252]\]. Calculations were performed using the SMD solvation model \[[@B22-molecules-22-02252]\] with dichloromethane as a solvent to mimic the reaction conditions (a). For compounds **2** and **3**, the angelate ester moiety was omitted since it had no influence on the conformation and, therefore, on the reactivity of the germacranolide ring, as previously shown \[[@B23-molecules-22-02252]\].

The global minimum structure of **2** ([Figure 1](#molecules-22-02252-f001){ref-type="fig"}) was stabilized by a non-conventional intramolecular hydrogen bond between O-3 and H-6 (distance O3-H6 2.23 Å). Upon treatment with acid, the epoxy group was protonated leading to the protonated reactant **A**. The intrinsic reaction coordinate of the transition state **B** involved the formation of a carbocation at C-10 requiring an activation energy of 5.03 kcal/mol. The occurrence of a transannular cyclization for **B** was precluded by the long distances of C10--C5 and C10--C4 (4.05 and 3.68 Å, respectively) due to the non-conventional intramolecular hydrogen bond between O-3 and H-6 (2.08 Å). Conversely, the close distance of O3--C1 (2.83 Å) enabled the formation of the protonated product **C**.

The reaction diagram of the conversion of **3** into **C**, a congener of micheliolide is shown in [Figure 2](#molecules-22-02252-f002){ref-type="fig"}, with the guaianolide scaffold resulting from the transannular cyclization. As in case of **2**, the energetically optimized conformation of **3** was stabilized by a non-conventional intramolecular hydrogen bond between O-3 and H-6 (2.33 Å). In acidic media, **3** would lead to the protonated epoxide **A**. However, evolution of **3** into transition state **B** bearing a C-5 carbocation would be prevented by the too high energy barrier of 12.7 kcal/mol.

Theoretical studies on the conversion of parthenolide into micheliolide ([Figure 3](#molecules-22-02252-f003){ref-type="fig"}) showed that the formation of the transition state **B** bearing the carbocation at C-5 was energetically more favored. Furthermore, key distances of C1--C5 (3.03 and 2.61 Å in **A** and **B**, respectively) allowed a transannular cyclization of the C1(10) double bond into the new bond C1--C5.

2.3. In Vitro Anti-Protozoal Activity {#sec2dot3-molecules-22-02252}
-------------------------------------

Considering the antiprotozoal activity of other sesquiterpene lactones \[[@B24-molecules-22-02252],[@B25-molecules-22-02252]\], compounds **1**, **3**--**8**, and **10**--**15** were tested for their in vitro activity against *Trypanosoma brucei rhodesiense*, *T. cruzi*, *Leishmania donovani*, and *Plasmodium falciparum* ([Table 5](#molecules-22-02252-t005){ref-type="table"})*.* In parallel, their cytotoxicity in L6 cells was evaluated in order to obtain a first appreciation of the selectivity. The tested compounds exhibited anti-protozoal activity in the micromolar range. Among the tested parasites, *T. b. rhodesiense* was generally found to be the most sensitive (IC~50~ 0.47--13.4 µM, Selectivity Index (SI) 0.3--4). Epoxides **3**--**4** were as active as nobilin (**1**) against *T. b. rhodesiense*. The anti-trypanosomal activity of furanoheliangolides **5**, **8**, and **10** varied depending on the substitution patterns. Decoration of the cyclodecadiene skeleton with more polar functional groups, e.g., a hydroxyl group as in **6** and **7** caused a doubling of activity. Acetylation of the alcoholic function at C-3 increased activity as observed in compounds **11**--**14** (IC~50~ 0.47--1.57 µM). However, all compounds showed significant cytotoxicity in L6 cells.

3. Experimental Section {#sec3-molecules-22-02252}
=======================

3.1. General Information {#sec3dot1-molecules-22-02252}
------------------------

Optical rotation was measured in MeOH (1 mg/mL) with a P-2000 digital polarimeter (Jasco, Tokyo, Japan) using a 10-cm microcell. UV and CD spectra were recorded in MeOH (120 μg/mL) on a Chirascan CD spectrometer, and data analyzed with Pro-Data V2.4 software. NMR spectra were recorded on a Bruker Avance III spectrometer operating at 500.13 MHz for ^1^H, and 125.77 MHz for ^13^C. ^1^H-NMR, COSY, HSQC, HMBC, and NOESY spectra were measured at 18 °C in a 1 mm TXI probe with a z-gradient, using standard Bruker pulse sequences. ^13^C-NMR/DEPTQ spectra were recorded at 23 °C in a 5 mm BBO probe with a z-gradient. Spectra were analyzed by Bruker TopSpin 3.0 (Bruker Biospin, Fällende, Zurich, Switzerland). The following abbreviations are used to describe the signal multiplicities: s (singlet), d (doublet), t (triplet), q (quartet,) and m (multiplet).

High-resolution mass spectra (ESI-TOF-MS) were recorded in positive mode on a Bruker microTOF ESIMS system. Nitrogen was used as a nebulizing gas at a pressure of 2.0 bar, and as drying gas at a flow rate of 9.0 L/min (dry gas temperature 240 °C). Capillary voltage was set at 45,000 V, and the hexapole at 230.0 Vpp. Instrument calibration was done with a reference solution of 0.1% sodium formiate in 2-propanol/water (1:1) containing 5 mM NaOH.

HPLC-PDA-ESIMS spectra were obtained in positive mode on a Bruker Daltonics Esquire 3000 Plus ion trap MS system, connected via T-splitter (1:10) to an Agilent HP 1100 system consisting of degasser, binary mixing pump, autosampler, column oven, and a diode array detector (G1315B). Data acquisition and processing was performed with Hystar 3.0 software (Bruker Optics, Fällende, Zurich, Switzerland). Semipreparative HPLC separations were carried out with an Agilent HP 1100 series system consisting of a quaternary pump, autosampler, column oven, and diode array detector (G1315B). Waters SunFire™ (Petaluma, CA, USA) (C18, 3.5 μm, 3.0 × 150 mm i.d.) and SunFire™ Prep C18 (5 μm, 10 × 150 mm i.d) columns were used for analytical and semi-preparative separations, respectively. HPLC-grade MeOH, acetonitrile, (Scharlau Chemie S.A., Barcelona, Spain) and water were used for HPLC separations. HPLC solvents contained 0.1% of HCO~2~H for analytical and semi-preparative separations. Dry toluene was obtained by passing commercially available analytical grade toluene (Scharlau Chemie S.A, Barcelona, Spain) through an activated alumina column. NMR spectra were recorded in methanol-*d*~4~ (Armar Chemicals). Technical-grade solvents purified by distillation were used for extraction and open column chromatography. Silica gel (63--200 μm and 15--40 μm, Merck, Kenilworth, NJ, USA) was used for open-column chromatography.

3.2. In Vitro Biological Testing {#sec3dot2-molecules-22-02252}
--------------------------------

Compounds were dissolved in DMSO (10 mg/mL) and stored at −20 °C until testing. Fresh dilutions in medium were prepared for each bioassay. The DMSO concentration in the assay did not exceed 1%. All assays were performed in at least three independent experiments. The purity of all compounds was \>95% unless stated otherwise.

The in vitro activities against the protozoan parasites *T. b. rhodesiense* (STIB900) bloodstream forms, *T. cruzi* (Tulahuen C4 LacZ) intracellular amastigotes, *L. donovani* (MHOM-ET-67/L82) axenically grown amastigotes, and *P. falciparum* (NF54) erythrocytic stage and cytotoxicity in L6 cells (rat skeletal myoblasts) were determined as reported elsewhere \[[@B26-molecules-22-02252]\].

3.3. Isolation of Nobilin *(**1**)* {#sec3dot3-molecules-22-02252}
-----------------------------------

Nobilin (**1**) was isolated from flower cones of *Anthemis nobilis* (Dixa AG, St. Gallen, Switzerland). Flowers were milled and percolated with *n*-hexane (2 × 5 L), followed by CH~2~Cl~2~ (2 × 5 L). The CH~2~Cl~2~ extract was dried and separated by CC on SiO~2~ (400--600 mesh), using a gradient of *n*-hexane/EtOAc (90:10 to 50:50) as mobile phase. Nobilin-enriched fractions were combined and purified by CC on SiO~2~ (400--150 mesh). A gradient of *n*-hexane/EtOAc 95:5 to 60:40 was used as mobile phase. After recrystallization from EtOAc/*n*-hexane, 800 mg of white solid were obtained. Spectroscopic data were identical to those reported in the literature. *R*~f~ = 0.80 (SiO~2~, *n*-hexane/EtOAc 60:40). ${\lbrack\mathsf{\alpha}\rbrack}_{D}^{25}$ = −21.67 (*c* = 0.44, CH~3~OH). ^1^H-NMR (CD~3~OD, 500 MHz): δ 1.74 (d, *J* = 1.4 Hz, 3H, 15-CH~3~), 1.87 (quint, *J* = 1.5 Hz, 3H, 5′-CH~3~), 1.89 (br s, 3H, 14-CH~3~), 1.93 (dq, *J* = 7.2 and 1.5 Hz, 3H, 4′-CH~3~), 2.23 (ddd, *J* = 13.8, 7.2 and 3.5 Hz, 1H, 2-H~b~), 2.46 (dd, *J* = 12.7 and 10.5 Hz, 1H, 9-H~b~), 2.50--2.68 (mov, 2H, 2-H~a~ and 9-H~a~), 3.05 (dq, *J* = 10.0, and 1.8 Hz, 1H, 7-H), 4.39 (dd, *J* = 3.5 and 2.8 Hz, 1H, 3-H), 5.03 (ddd, *J* = 10.5, 10.0 and 3.7 Hz, 1H, 8-H), 5.17 (dq, *J* = 10.4 and 1.4 Hz, 1H, 5-H) 5.37 (dd, *J* = 9.3 and 7.2 Hz, 1H, 1-H), 5.70 (br s, 1H, 13-H~b~), 6.05 (dd, *J* = 10.4 and 1.8 Hz, 1H, 6-H), 6.11 (qq, *J* = 7.2 and 1.5 Hz, 1H, 3′-H), 6.20 (br s, 1H, 13-H~a~) ppm. ^13^C-NMR (CD~3~OD, 125 MHz): δ 16.1 (CH~3~, 4′-C), 18.6 (CH~3~, 14-C), 20.6 (CH~3~, 5′-C), 23.6 (CH~3~, 15-C), 32.5 (CH~2~, 2-C), 49.0 (CH~2~, 9-C), 52.2 (CH, 7-C), 71.3 (CH, 8-C), 77.4 (CH, 3-C), 79.4 (CH, 6-C), 126.2 (CH, 5-C), 127.0 (CH, 1-C), 127.3 (CH~2~, 13-C), 128.9 (C, 2′-C), 134.6 (C, 10-C), 137.3 (C, 11-C), 139.9 (CH, 3′-C), 142.4 (C, 4-C), 168.3 (C, 1′-C), 172.4 (C, 12-C) ppm. HR-ESIMS calculated for C~20~H~26~O~5~Na \[M + Na\]^+^, 369.1672; found, 369.1672. The CD spectrum ([Figure S62](#app1-molecules-22-02252){ref-type="app"}) was in agreement with the literature \[[@B14-molecules-22-02252]\].

3.4. Synthesis of Compounds ***2*** and ***4*** {#sec3dot4-molecules-22-02252}
-----------------------------------------------

To a stirred solution of **1** (200 mg; 0.58 mmol) in DCM (10 mL), a solution of mCPBA (77%; 207 mg; 0.93 mmol) in DCM (1 mL) was added under cooling with ice. The reaction mixture was then allowed to stand at room temperature for 4 h. On the basis of a TLC analysis, the reaction was quenched by the addition of 10% Na~2~S~2~O~3~ (2 × 5 mL). The absence of peroxides was tested with KI paper. The organic phase was then dried under Na~2~S~2~O~4~ and the solvent removed under reduced pressure. The obtained residue was purified by chromatography (SiO~2~; *n*-hexane/AcOEt) to afford **2** (140 mg; 0.39 mmol; 70%), **3** (10 mg; 0.028 mmol; 7%), and **4** (9 mg; 0.024 mmol; 4%) as white solids.

*(−)-(1R,10R)-1,10-Epoxynobilin* (**2**) *R*~f~ = 0.5 (SiO~2~, hexane/EtOAc 60:40). ${\lbrack\mathsf{\alpha}\rbrack}_{D}^{25}$ = −16.9 (*c* = 0.1, CH~3~OH). ^1^H-NMR (CD~3~OD, 500 MHz): δ 1.48 (dd, *J* = 13.0, and 11.5 Hz, 1H, 9-H~ax~), 1.53 (s, 3H, 14-CH~3~), 1.63 (ddd, *J* = 14.5, 10.2 and 2.6 Hz, 1H, 2-H~ax~), 1.80 (br s, 3H, 15-CH~3~), 1.85 (quint, *J* = 1.5 Hz, 3H, 5′-CH~3~), 1.92 (dq, *J* = 7.0 and 1.5 Hz, 3H, 4′-CH~3~), 2.48 (ddd, *J* = 14.5, 4.5 and 4.3 Hz, 1H, 2-H~eq~), 2.50 (dd, *J* = 13.0, and 3.0 Hz, 1H, 9-H~eq~), 2.94 (dd, *J* = 10.2, and 4.5 Hz, 1H, 1-H), 3.04 (dq, *J* = 10.0, and 1.6 Hz, 7-H), 4.40 (dd, *J* = 4.3 and 2.6 Hz, 1H, 3-H), 5.08 (ddd, *J* = 11.5, 10.0, and 3.0 Hz, 1H, 8-H), 5.27 (dq, *J* = 10.8, and 1.4 Hz, 1H, 5-H), 5.71 (br s, 1H, 13-H~b~), 6.12 (qq, *J* = 7.0 and 1.5 Hz, 1H, 3′-H), 6.22 (br m, 1H, 13-H~a~), 6.38 (dd, *J* = 10.8, and 1.6 Hz, 1H, 6-H) ppm. ^13^C-NMR (CD~3~OD, 125 MHz, extracted from HSQCC and HMBC spectra): δ 14.5 (CH~3~, 4′-C), 17.2 (CH~3~, 14-C), 19.1 (CH~3~, 5′-C), 21.9 (CH~3~, 15-C), 32.7 (CH~2~, 2-C), 46.8 (CH~2~, 9-C), 50.7 (CH, 7-C), 57.7 (C, 10-C), 60.7 (CH, 1-C), 69.4 (CH, 8-C), 71.2 (CH, 3-C), 76.1 (CH, 6-C), 124.3 (CH, 5-C), 126.0 (CH~2~, 13-C), 127.3 (C, 2′-C), 135.4 (C, 11-C), 138.4 (CH, 3′-C), 142.1 (C, 4-C), 166.8 (C, 1′-C), 170.3 (C, 12-C) ppm. HR-ESIMS calculated for C~20~H~26~O~6~Na \[M + Na\]^+^, 385.1622; found, 385.1637.

The ECD spectrum of **2** ([Figure S62](#app1-molecules-22-02252){ref-type="app"}) was in agreement with the literature \[[@B14-molecules-22-02252]\].

*(−)-(1R,4S,5R,10R)-1(10),4(5)-Diepoxynobilin* (**4**): *R*~f~ = 0.30 (SiO~2~, *n*-hexane/EtOAc 60:40). ${\lbrack\mathsf{\alpha}\rbrack}_{D}^{25}$ = −16.2 (*c* = 0.1, CH~3~OH). ^1^H-NMR (CDCl~3~, 500 MHz): δ 1.40 (s, 3H, 15-CH~3~), 1.45 (overlapped, 1H, 9-H~ax~), 1.46 (br s, 3H, 14-CH~3~), 1.80 (overlapped, 1H, 2-H~ax~), 1.82 (quint, *J* = 1.5 Hz, 3H, 5′-CH~3~), 1.92 (dq, *J* = 7.0 and 1.5 Hz, 3H, 4′-CH~3~), 2.52 (dt, *J* = 15.0 and 4.2 Hz, 1H, 2-H~eq~), 2.60 (dd, *J* = 13.2, and 2.5 Hz, 1H, 9-H~eq~), 2.85 (d, *J* = 9.7 Hz, 1H, 5-H), 2.96 (dd, *J* = 10.6, and 4.2 Hz, 1H, 1-H), 3.07 (br d, *J* = 9.4 Hz, 7-H), 4.28 (dd, *J* = 4.2 and 3.0 Hz, 1H, 3-H), 5.02 (ddd, *J* = 12.0, 9.4 and 2.5 Hz, 1H, 8-H), 5.36 (br d, *J* = 9.7 Hz, 1H, 6-H), 5.73 (br m, 1H, 13-H~b~), 6.06 (qq, *J* = 7.2 and 1.5 Hz, 1H, 3′-H), 6.34 (br m, 1H, 13-H~a~) ppm. ^13^C-NMR (CDCl~3~, 125 MHz): δ 15.8 (CH~3~, 4′-C), 17.7 (CH~3~, 14-C), 20.0 (CH~3~, 15-C), 20.3 (CH~3~, 5′-C), 30.6 (CH~2~, 2-C), 47.4 (CH~2~, 9-C), 49.2 (CH, 7-C), 57.8 (C, 10-C), 58.9 (CH, 1-C), 62.4 (C, 4-C), 63.4 (CH, 5-C), 68.5 (CH, 8-C), 69.1 (CH, 3-C), 75.8 (CH, 6-C), 126.9 (C, 2′-C), 128.1 (CH~2~, 13-C), 133.3 (C, 11-C), 140.0 (CH, 3′-C), 166.1 (C, 1′-C), 168.9 (C, 12-C) ppm. HR-ESIMS calculated for C~20~H~26~O~7~Na \[M + Na\]^+^, 401.1571; found, 401.1588.

3.5. Synthesis of Compound ***3*** {#sec3dot5-molecules-22-02252}
----------------------------------

To a stirred solution of **1** (60 mg; 0.17 mmol) in DCM (3 mL), VO(acac)~2~ (14 mg; 0.05 mmol) and *t*BHP (solution 5.5 M in decane; 42 μL; 0.2 mmol) were added under ice and argon atmosphere. The reaction mixture was then allowed to stand at room temperature for 12 h. After TLC monitoring, the reaction was quenched by adding 10% Na~2~S~2~O~3~ (2 × 5 mL). The absence of peroxides was tested with KI paper. The organic phase was dried under Na~2~S~2~O~4~, the solvent was removed under reduced pressure, and the obtained residue was purified by chromatography (SiO~2~; *n*-hexane/AcOEt 70:30) to give **3** (54 mg; 0.15 mmol; 88%) as a white solid.

*(−)-(4S,5R)-4,5-Epoxynobilin* (**3**): *R*~f~ = 0.70 (SiO~2~, *n*-hexane/EtOAc 60:40). ${\lbrack\mathsf{\alpha}\rbrack}_{D}^{25}$ = −6.19 (*c* = 0.1, CH~3~OH). ^1^H-NMR (CDCl~3~, 500 MHz): δ 1.34 (br s, 3H, 15-CH~3~), 1.82 (br s, 3H, 14-CH~3~), 1.84 (quint, *J* = 1.5 Hz, 3H, 5′-CH~3~), 1.93 (dq, *J* = 7.0 and 1.5 Hz, 3H, 4′-CH~3~), 2.23 (ddd, *J* = 14.4, 7.0 and 3.6 Hz, 1H, 2-H~eq~), 2.37 (dd, *J* = 12.0, and 11.0 Hz, 1H, 9-H~ax~), 2.59 (dd, *J* = 12.0, and 3.7 Hz, 1H, 9-H~eq~), 2.76 (dd, *J* = 14.4, 10.2, and 2.6 Hz, 1H, 2-H~ax~), 2.69 (br d, *J* = 9.7 Hz, 5-H), 3.05 (dddd, *J* = 9.7, 1.5,. 1.0, and 1.0 Hz, 7-H), 4.20 (dd, *J* = 3.6, and 2.6 Hz, 1H, 3-H), 4.92 (dd, *J* = 9.7, and 1.0 Hz, 1H, 6-H), 5.01 (ddd, *J* = 11.0, 9.7, and 3.7 Hz, 1H, 8-H), 5.40 (ddd, *J* = 10.2, 7.0, and 1.0 Hz, 1H, 1-H), 5.70 (dd, *J* = 1.5, and 0.8 Hz, 1H, 13-H~b~), 6.07 (qq, *J* = 7.0 and 1.5 Hz, 1H, 3′-H), 6.33 (br m, 1H, 13-H~a~) ppm. ^13^C-NMR (CDCl~3~, 125 MHz): δ 15.7 (CH~3~, 4′-C), 18.0 (CH~3~, 14-C), 20.0 (CH~3~, 15-C), 20.2 (CH~3~, 5′-C), 28.4 and 28.3 (CH~2~, 2-C), 46.8 (CH~2~, 9-C), 48.5 (CH, 7-C), 62.9 (C, 4-C), 63.8 (CH, 5-C), 69.3 (CH, 8-C), 73.2 and 73.1 (CH, 3-C), 77.4 (CH, 6-C), 122.9 (CH, 1-C), 127.1 (C, 2′-C), 127.4 (CH~2~, 13-C), 133.8 (C, 11-C), 135.0 (C, 10-C), 139.2 (CH, 3′-C), 166.2 (C, 1′-C), 169.1 (C, 12-C) ppm HR-ESIMS calculated for C~20~H~26~O~6~Na \[M + Na\]^+^, 385.1622; found, 385.1639. The ECD spectrum is reported in the [Supplementary Materials (Figure S62)](#app1-molecules-22-02252){ref-type="app"}.

3.6. General Procedure for Degradation with p-TsOH·H~2~O {#sec3dot6-molecules-22-02252}
--------------------------------------------------------

*p*-TsOH·H~2~O (1--2 mg) was added to a solution of epoxy derivatives **2**--**4** and **11**--**12** (20 mg; 0.055 mmol for **2** and **3**; 0.053 mmol for **4**; 0.050 mmol for **11** and **12**, respectively) in dichloromethane (3 mL), and stirred at 20 °C. After the starting material (TLC on SiO~2~, *n*-hexane/EtOAc 40:60) disappeared, the reaction was quenched with aqueous Na~2~HPO~4~ 0.5 N (2 mL). The layers were separated, and the organic layer dried over Na~2~SO~4~ and concentrated in vacuo to give a brownish oil. The major reaction products were isolated by semi-preparative HPLC (gradient of H~2~O/CH~3~CN; detection at 220 nm).

*(+)-(4Z,1R,3R,6R,7R,8S,10S)-8-Angeloxy-3,10-epoxy-1-hydroxy-germacra-4(5),11(13)-dien-6,12-olide* (**5**): white solid (10 mg, 0.027 mmol, 50%); ${\lbrack\mathsf{\alpha}\rbrack}_{D}^{25}$ = +6.85 (*c* 0.1, MeOH); for ^1^H and ^13^C-NMR data, see [Table 1](#molecules-22-02252-t001){ref-type="table"} and [Table 3](#molecules-22-02252-t003){ref-type="table"}, respectively. HRESIMS *m*/*z* 385.1632 \[M + Na\]^+^ (calculated for C~20~H~26~NaO~6~: 385.1622).

*(4Z,9E,1R,3S,6R,7S,8S)-8-Angeloxy-1,3-dihydroxy-germacra-4(5),9(10),11(13)-trien-6,12-olide and (4Z,9Z,1R,3S,6R,7S,8S)-8-Angeloxy-1,3-dihydroxy-germacra-4(5),9(10),11(13)-trien-6,12-olide* (**6** and **7**): white solid (2 mg, 0.006 mol, 11% in a ratio of 3:1); for ^1^H and ^13^C-NMR data, see [Table 1](#molecules-22-02252-t001){ref-type="table"} and [Table 3](#molecules-22-02252-t003){ref-type="table"}, respectively. HRESIMS *m*/*z* 385.1644 \[M + Na\]^+^ (calculated for C~20~H~26~NaO~6~: 385.1622).

*(+)-(1R,3R,4S,5R,6S,7R,8S,10S)-8-Angeloxy-3(10),4(5)-diepoxy-germacra-11(13)-en-6,12-olide* (**8**): white solid (8 mg, 0.02 mol, 40%); ${\lbrack\mathsf{\alpha}\rbrack}_{D}^{25}$ = +3.75 (*c* 0.1, MeOH); for ^1^H and ^13^C-NMR data, see [Table 1](#molecules-22-02252-t001){ref-type="table"} and [Table 3](#molecules-22-02252-t003){ref-type="table"}, respectively. HRESIMS *m*/*z* 401.1591 \[M + Na\]^+^ (calculated for C~20~H~26~NaO~7~: 401.1571).

*(−)-(1R,3R,4S,5S,6S,7R,8S,10S)-8-Angeloxy-3,10-epoxy-4-hydroxy-5-tosyloxygermacra-11(13)-en-6,12-olide* (**9**): white solid (2.7 mg, 0.005 mol, 10%); ${\lbrack\mathsf{\alpha}\rbrack}_{D}^{25}$ = −2.9 (*c* 0.2, MeOH); for ^1^H and ^13^C-NMR data, see [Table 1](#molecules-22-02252-t001){ref-type="table"} and [Table 3](#molecules-22-02252-t003){ref-type="table"}, respectively. HRESIMS *m*/*z* 573.1786 \[M + Na\]^+^ (calculated for C~27~H~34~NaO~10~S: 573.1765).

*(+)-(1Z,4Z,3S,6R,7R,8S,10S)-8-Angeloxy-3,10-epoxy-3-hydroxy-germacra-1(2),4(5),11(13)-trien-6,12-olide* (**10**): white solid (2.2 mg, 0.06 mol, 12%); ${\lbrack\mathsf{\alpha}\rbrack}_{D}^{25}$ = +2.87 (*c* 0.1, MeOH); for ^1^H and ^13^C-NMR data, see [Table 1](#molecules-22-02252-t001){ref-type="table"} and [Table 3](#molecules-22-02252-t003){ref-type="table"}, respectively. HRESIMS *m*/*z* 383.1500 \[M + Na\]^+^ (calculated for C~20~H~24~NaO~6~: 383.1465).

*(+)-(4Z,9E,1R,3S,6R,7S,8S)-3-Acetoxy-8-angeloxy-1-hydroxy-germacra-4(5),9(10),11(13)-trien-6,12-olide* (**13**): white solid (2 mg, 0.005 mol, 10%); ${\lbrack\mathsf{\alpha}\rbrack}_{D}^{25}$ = +78.66 (*c* 0.5, MeOH); for ^1^H and ^13^C-NMR data, see [Table 2](#molecules-22-02252-t002){ref-type="table"} and [Table 4](#molecules-22-02252-t004){ref-type="table"}, respectively. HRESIMS *m*/*z* 427.1749 \[M + Na\]^+^ (calculated for C~22~H~28~NaO~7~: 427.1727).

*(+)-(4Z,1R,3S,6R,7R,8S)-3-Acetoxy-8-angeloxy-1-hydroxy-germacra-4(5),10(14),11(13)-trien-6,12-olide* (**14**): white solid (1 mg, 0.002 mol, 5%); ${\lbrack\mathsf{\alpha}\rbrack}_{D}^{25}$ = +51.75 (*c* 0.1, MeOH); for ^1^H and ^13^C-NMR data, see [Table 2](#molecules-22-02252-t002){ref-type="table"} and [Table 4](#molecules-22-02252-t004){ref-type="table"}, respectively. HRESIMS *m*/*z* 427.1749 \[M + Na\]^+^ (calculated for C~22~H~28~NaO~7~: 427.1727).

3.7. General Procedure for Degradation with BF~3~·Et~2~O {#sec3dot7-molecules-22-02252}
--------------------------------------------------------

To a solution of epoxy derivatives **2**--**4** and **11**--**12** (20 mg; 0.055 mmol for **2** and **3**; 0.053 mmol for **4**; 0.050 mmol for **11** and **12**, respectively) in anhydrous toluene (5 mL), BF~3~·Et~2~O (5 μL) was added under cooling in ice, and stirred at 20 °C. After disappearing of the starting material (TLC on SiO~2~, *n*-hexane/EtOAc 40:60) the reaction was quenched with aqueous Na~2~HPO~4~ 0.5 N (10 mL). The layers were separated, and the organic layer dried over Na~2~SO~4~ and concentrated to dryness under reduced pressure. The major reaction products were isolated by semi-preparative HPLC (gradient of CH~3~CN/H~2~O; detection at 220 nm). Yields for individual compounds are reported in [Scheme 2](#molecules-22-02252-sch002){ref-type="scheme"}, [Scheme 3](#molecules-22-02252-sch003){ref-type="scheme"} and [Scheme 4](#molecules-22-02252-sch004){ref-type="scheme"}.

*(+)-(7R,8S,10S)-8-Angeloxy-3-hydroxy-7,8,9,10-tetrahydro-cadalen-11(13)-en-12-oic acid* (**15**): white solid (6.8 mg, 0.02 mol, 40%); ${\lbrack\mathsf{\alpha}\rbrack}_{D}^{25}$ = +82.95 (*c* 0.1, MeOH); for ^1^H and ^13^C-NMR data, see [Table 2](#molecules-22-02252-t002){ref-type="table"} and [Table 4](#molecules-22-02252-t004){ref-type="table"}, respectively. HRESIMS *m*/*z* 367.1530 \[M + Na\]^+^ (calculated for C~20~H~24~NaO~5~: 367.1516).

*Cadalen-11(13)-en-12-oic acid* (**16**): white solid (1.1 mg, 0.005 mol, 10%); for ^1^H and ^13^C-NMR data, see [Table 2](#molecules-22-02252-t002){ref-type="table"} and [Table 4](#molecules-22-02252-t004){ref-type="table"}, respectively. HRESIMS *m*/*z* 249.0899 \[M + Na\]^+^ (calculated for C~15~H~14~NaO~2~: 249.0886).

3.8. General Procedure for Synthesis of Compounds ***11*** and ***12*** {#sec3dot8-molecules-22-02252}
-----------------------------------------------------------------------

To a stirred solution of epoxy derivatives **2** and **3** (20 mg: 0.055 mmol) in dichlomethane (2 mL), acetic anhydride (35 μL; 0.37 mmol), Hünig's base (20 μL; 0.12 mmol) and DMAP (cat.) were added. After disappearance of the starting material (TLC on SiO~2~, *n*-hexane/EtOAc 70:30) the reaction was quenched by adding HCl 0.5 M (2 mL). The layers were separated and the organic layer dried over Na~2~SO~4~ and concentrated to dryness under reduced pressure. Compounds **11** (17.8 mg; 80%) and **12** (15.5 mg; 70%) were isolated by chromatography on SiO~2~ (*n*-hexane/EtOAc 70:30; detection with phosphomolybdic acid).

*(+)-(1R,10R)-3-Acetoxy-1,10-epoxy nobilin* (**11**): *R*~f~ = 0.3 (SiO~2~, hexane/EtOAc 60:40). ${\lbrack\mathsf{\alpha}\rbrack}_{D}^{25}$ = +13.12 (*c* = 0.1, CHCl~3~). ^1^H-NMR (CDCl~3~, 500 MHz): δ 1.36 (dd, *J* = 13.2, and 11.3 Hz, 1H, 9-H~ax~), 1.52 (s, 3H, 14-CH~3~), 1.66 (br dd, *J* = 10.2, and 4.5 Hz, 1H, 2-H~ax~), 1.81 (quint, *J* = 1.5 Hz, 3H, 5′-CH~3~), 1.85 (d, *J* = 1.5 Hz, 3H, 15-CH~3~), 1.91 (dq, *J* = 7.0 and 1.5 Hz, 3H, 4′-CH~3~), 2.08 (s, 3H,2″), 2.53 (ddd, *J* = 15.5, 5.0 and 4.5 Hz, 1H, 2-H~eq~), 2.58 (dd, *J* = 13.2, and 3.0 Hz, 1H, 9-H~eq~), 2.83 (br dd, *J* = 10.2, and 4.5 Hz, 1H, 1-H), 2.85 (dq, *J* = 10.5, and 1.5 Hz, 7-H), 5.06 (ddd, *J* = 11.3, 10.5, and 3.0 Hz, 1H, 8-H), 5.20 (dd, *J* = 5.0, and 2.2 Hz, 1H, 3-H), 5.22 (dq, *J* = 11.0, and 1.5 Hz, 1H, 5-H), 5.65 (dd, *J* = 11.0, and 1.5 Hz, 1H, 6-H), 5.66 (br m, 1H, 13-H~b~), 6.05 (qq, *J* = 7.0 and 1.5 Hz, 1H, 3′-H), 6.29 (br m, 1H, 13-H~a~), ppm. ^13^C-NMR (Extracted from HSQC and HMBC spectra; CDCl~3~, 125 MHz): δ 15.6 (CH~3~, 4′-C), 17.2 (CH~3~, 14-C), 20.2 (CH~3~, 5′-C), 21.0 (CH~3~, 2″), 22.8 (CH~3~, 15-C), 30.2 (CH~2~, 2-C), 46.8 (CH~2~, 9-C), 50.7 (CH, 7-C), 57.7 (C, 10-C), 60.3 (CH, 1-C), 69.0 (CH, 8-C), 72.6 (CH, 3-C), 75.2 (CH, 6-C), 125.0 (CH, 5-C), 127.0 (CH~2~, 13-C), 127.4 (C, 2′-C), 134.0 (C, 11-C), 139.0 (CH, 3′-C), 139.0 (C, 4-C), 166.4 (C, 1′-C), 168.9 (C, 12-C), 169.3 (C, 1″~3~) ppm. HR-ESIMS calculated for C~22~H~28~O~7~Na \[M + Na\]^+^, 427.1727; found, 427.1753.

*(+)-(4S,5R)-3-Acetoxy-4,5-epoxy nobilin* (**12**): *R*~f~ = 0.2 (SiO~2~, *n*-hexane/EtOAc 60:40). ${\lbrack\mathsf{\alpha}\rbrack}_{D}^{25}$ = +94.97 (*c* = 0.1, CHCl~3~). ^1^H-NMR (CDCl~3~, 500 MHz): δ 1.36 (br s, 3H, 15-CH~3~), 1.79 (br s, 3H, 14-CH~3~), 1.83 (quint, *J* = 1.5 Hz, 3H, 5′-CH~3~), 1.92 (dq, *J* = 7.0 and 1.5 Hz, 3H, 4′-CH~3~), 2.02 (s, 3H,2″), 2.37 (ddd, *J* = 15.0, 7.0 and 3.0 Hz, 1H, 2-H~eq~), 2.40 (dd, *J* = 12.8, and 11.0 Hz, 1H, 9-H~ax~), 2.56 (br d, *J* = 9.7 Hz, 5-H), 2.58 (dd, *J* = 12.8, and 3.6 Hz, 1H, 9-H~eq~), 2.76 (dd, *J* = 15.0, 10.0, and 2.5 Hz, 1H, 2-H~ax~), 3.06 dq, *J* = 9.9, 1.5 Hz, 7-H), 4.61 (dd, *J* = 9.7, and 1.5 Hz, 1H, 6-H), 5.03 (ddd, *J* = 11.0, 9.9, and 3.6 Hz, 1H, 8-H), 5.36 (br t, *J* = 3.0 Hz, 1H, 3-H), 5.48 (ddd, *J* = 10.0, 7.0, and 1.0 Hz, 1H, 1-H), 5.69 (br m, 1H, 13-H~b~), 6.05 (qq, *J* = 7.0 and 1.5 Hz, 1H, 3′-H), 6.31 (br m, 1H, 13-H~a~) ppm. ^13^C-NMR (Extracted from HSQC and HMBC spectra; CDCl~3~, 125 MHz): δ 15.7 (CH~3~, 4′-C), 18.0 (CH~3~, 14-C), 20.2 (CH~3~, 5′-C), 20.5 (CH~3~, 15-C), 20.9 (CH~3~,2″), 27.6 (CH~2~, 2-C), 46.8 (CH~2~, 9-C), 48.7 (CH, 7-C), 60.5 (C, 4-C), 62.4 (CH, 5-C), 69.4 (CH, 8-C), 72.9 (CH, 3-C), 77.6 (CH, 6-C), 122.8 (CH, 1-C), 127.0 (C, 2′-C), 127.3 (CH~2~, 13-C), 134.0 (C, 11-C), 135.0 (C, 10-C), 139.2 (CH, 3′-C), 166.1 (C, 1′-C), 169.0 (C, 12-C), 169.2 (C,2″) ppm. HR-ESIMS calculated for C~22~H~28~O~7~Na \[M + Na\]^+^, 427.1727; found, 427.1748.

3.9. Computational Methods {#sec3dot9-molecules-22-02252}
--------------------------

Conformational analysis of parthenolide, **2**, **3**, and **5** was performed with Schrödinger MacroModel 9.8 (Schrödinger, LLC, New York, NY, USA) employing the OPLS_2005 (Optimized Potentials for Liquid Simulations) force field. For parthenolide, **2** and **3**, the calculations were done with the chloroform solvation model (N.B. the dichloromethane solvation model is not available within MacroModel). Conformers within a 2.0 kcal/mol energy window from the global minimum were selected for geometrical optimization and energy calculation. Structural optimizations, transition state (TS) searches, and vibrational calculations were carried out by applying DFT with the Becke's nonlocal three-parameter exchange and correlation functional, and the Lee--Yang--Parr correlation functional level (B3LYP) using the 6-31+G(d,p) basis set in combination with the SMD solvation model \[[@B21-molecules-22-02252]\] (solvent = dichloromethane), as implemented in the Gaussian 09 program package \[[@B27-molecules-22-02252]\]. At optimized geometries, vibrational analysis was performed, yielding one imaginary frequency for the transition states and no imaginary frequencies for other molecular species.

4. Conclusions {#sec4-molecules-22-02252}
==============

A study of the reactivity of nobilin epoxy derivatives in acidic media has been carried out through chemical and theoretical analysis. In agreement with what has been reported for similar epoxy heliangolides \[[@B28-molecules-22-02252]\], the type of rearrangement that compounds **2**--**4** undergo under acidic catalysis depends solely on their conformation, which activates or deactivates the latent reactivity of functional groups towards a structural rearrangement. Provided that the epoxy group and olefin, can provide an nucleophilic site that can trigger a subsequent rearrangement, the reactivity of the 1,10-epoxide towards electrophiles, similar to what has been observed for the corresponding 1(10)-olefin of **1**, is much higher than that of the 4,5-epoxide. A key role in deactivating the reactivity of the latter epoxide could be played by the 3-hydroxy group, which stabilizes the germacranolide skeleton through non-conventional hydrogen bonding with H-6. This assumption would explain the different reactivity of parthenolide compared to that of compounds **3** and **13**. Nevertheless, the high reactivity of the hydroxyl function at C-3 towards the C-10 carbocation provides easy access to the class of furanoheliangolides with good yield. Since many of the isolated products are structurally related to natural products, the present study provides new insight into the mechanism of natural sesquiterpene-forming reactions.

ECD spectra were measured at the Biophysics Facility, Biozentrum, University of Basel. Maria De Mieri gratefully acknowledges Francesco Barbieri for proofreading the manuscript.

**Sample Availability:** Samples of the compounds **1** and **2** are available from the authors.

Supplementary data associated with this article can be found in the online version.
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![Structures of nobilin **1** and epoxy derivatives **2**--**4**. The carbon numbering follows the semi-systematic nomenclature of sesquiterpenes.](molecules-22-02252-sch001){#molecules-22-02252-sch001}

![Reactivity of **2** with acids.](molecules-22-02252-sch002){#molecules-22-02252-sch002}

![Reactivity of **4** with acids.](molecules-22-02252-sch003){#molecules-22-02252-sch003}

![Reactivity of **11** and **12** with acids.](molecules-22-02252-sch004){#molecules-22-02252-sch004}

![Reactivity of **3** and parthenolide with acids.](molecules-22-02252-sch005){#molecules-22-02252-sch005}

![Energy profile of the transformation of **2** into **5**. Relative energies are reported in kcal/mol. The hydrogen bonding interaction O-3...H-6 is represented with a dashed line.](molecules-22-02252-g001){#molecules-22-02252-f001}

![Energy profile of the putative transannular cyclization of **3**. Relative energies are reported in kcal/mol. The hydrogen bonding interaction O-3...H-6 is represented with a dashed line.](molecules-22-02252-g002){#molecules-22-02252-f002}

![Energy profile of the transformation of parthenolide into micheliolide. Relative energies are reported in kcal/mol.](molecules-22-02252-g003){#molecules-22-02252-f003}

molecules-22-02252-t001_Table 1

###### 

^1^H-NMR spectroscopic data for compounds **5**--**10** (CD~3~OD for **5**--**9**, CDCl~3~ for **10**; 500.13 MHz; δ in ppm).

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Position   5 δ~H~\                           6 δ~H~\                           7 δ~H~\                           8 δ~H~\                           9 ^b^ δ~H~\                   10 δ~H~\
             (mult, *J* in Hz)                 (mult, *J* in Hz)                 (mult, *J* in Hz)                 (mult, *J* in Hz)                 (mult, *J* in Hz)             (mult, *J* in Hz)
  ---------- --------------------------------- --------------------------------- --------------------------------- --------------------------------- ----------------------------- ----------------------------------
  1          3.85 (br d, 4.6)                  4.05 (dd, 10.6, 6.5)              4.96 (dd, 10.2, 3.0)              3.90 (d, 4.3)                     3.96 (dd, 5.2, 1.4)           6.22 (d, 5.7)

  2          2.32--2.20 ^a^                    1.94 ^a^\                         2.03 (ddd, 14.5, 3.8, 3.0)\       2.12 (dd, 13.8, 6.8)\             1.82 (ddd, 13.2, 6.2, 1.4)\   5.89 (d, 5.7)
                                               2.36 (ddd, 14.5, 6.6, 4.5)        2.19 (ddd, 14.5, 10.2, 3.7)       2.44 (ddd, 13.8, 11.0, 4.3)       2.41 (ddd, 13.2, 11.4, 5.2)   

  3          4.79 (dd, 8.6, 8.3)               4.49 ^a^                          4.49 ^a^                          4.63 (dd, 11.0, 6.8)              4.22 (dd, 11.4, 6.2)          \-

  4          \-                                \-                                \-                                \-                                \-                            \-

  5          5.26 (dq, 7.2, 1.5)               5.27 (dq, 10.5, 1.5)              5.39 (dq, 10.5, 1.5)              3.06 (d, 7.3)                     4.79 (br s)                   5.48 (dq, 5.8, 1.2)

  6          6.14 ^a^                          6.00 (dd, 10.5, 9.5)              6.38 (dd, 10.5, 9.2)              5.25 (dd, 7.3, 5.5)               5.63 (br d, 5.7)              5.95 (ddq, 5.8, 5.2, 1.2)

  7          3.08 (dddd, 9.0, 7.5, 3.0, 3.0)   3.09 (dddd, 9.5, 9.5, 3.5, 3.0)   3.02 (dddd, 9.5, 9.2, 3.5, 3.0)   3.35 (dddd, 9.0, 5.5, 2.6, 2.5)   3.31 (m)                      3.26 (dddd, 10.5, 5.2, 2.8, 2.5)

  8          5.33 (dd, 9.5, 9.0)               5.57 (dd, 10.2, 9.5)              6.00 (dd, 10.5, 9.5)              5.00 (dd, 9.8, 9.0)               5.06 (ddd, 10.0, 6.9, 1.2)    5.17 (ddd, 10.5, 5.0, 3.2)

  9          2.09 (dd, 14.8, 9.5)\             5.18 (dq, 10.2, 1.5)              5.30 (dq, 10.5, 1.5)              1.87 ^a^ β\                       1.91 ^a^\                     2.14 (dd, 15.4, 5.0)\
             1.70 (d, 14.8)                                                                                        2.05 (br dd, 14.6, 9.8)           2.13 (dd, 14.3, 10.3)         2.22 (dd, 15.4, 3.2)

  10         \-                                \-                                \-                                \-                                \-                            \-

  11         \-                                \-                                \-                                \-                                \-                            \-

  12         \-                                \-                                \-                                \-                                \-                            \-

  13         5.65 (dd, 3.0, 0.7)\              5.71 (d, 3.0)\                    5.85 (d, 3.0)\                    5.74 (br d, 2.5)\                 5.41 (br d, 2.5)\             5.89 (br d, 2.5)\
             6.17 ^a^                          6.16 (d, 3.5)                     6.25 (d, 3.5)                     6.23 (br d, 2.8)                  5.86 (br d, 2.8)              6.22 br d, 2.8)

  14         1.49 (s)                          1.95 (d, 1.5)                     1.80 (d, 1.5)                     1.37 (br s)                       1.33 (s)                      1.53 (s)

  15         1.66 (br s)                       1.76 (d, 1.5)                     1.79 (d, 1.5)                     1.27 (s)                          1.18 (br s)                   1.73 (t, 1.2)

  1′         \-                                \-                                \-                                \-                                \-                            \-

  2′         \-                                \-                                \-                                \-                                \-                            \-

  3′         6.17 (qq, 7.0, 1.5)               6.20 (qq, 7.0, 1.5)               6.20 (qq, 7.0, 1.5)               6.16 (qq, 7.0, 1.5)               6.15 (br q, 7.2)              6.16 (br q, 7.2)

  4′         1.96 (dq, 7.0, 1.5)               1.95 (dq 7.0, 1.5)                1.98 (dq 7.0, 1.5)                1.94 (dq 7.0, 1.5)                1.91 (br d, 7.2)              2.00 (br d, 7.2)

  5′         1.89 (quint, 1.5)                 1.89 (quint, 1.5)                 1.91 (quint, 1.5)                 1.88 (quint, 1.5)                 1.84 (quint, 1.5)             1.91 (quint, 1.5)
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^ Overlapped signals; ^b^ *p*-toluenesulphonate group: H-2, H-2′ δ~H~ = 7.76 pseudo d, *J* = 8.3 Hz; H-3, H-3′ δ~H~ = 7.41 pseudo d, *J* = 8.3 Hz; -CH*~3~* δ~H~ = 2.45, s.
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###### 

^13^C-NMR spectroscopic data for compounds **5**--**8** (CD~3~OD for **5**--**9**, CDCl~3~ for **10**; 125.77 MHz; δ in ppm).

  Position   5 δ~C~         6 δ~C~         7 δ~C~ ^a^     8 δ~C~            9 δ~C~ ^c^     10 δ~C~ ^a^
  ---------- -------------- -------------- -------------- ----------------- -------------- --------------
  1          77.6, CH       76.2, CH       69.4, CH       77.9, CH          78.8, CH       139.3, CH
  2          41.8, CH~2~    38.9, CH~2~    37.0, CH~2~    39.0, CH~2~       36.6, CH~2~    128.3, CH
  3          81.7, CH       74.1, CH       74.9, CH       78.6, CH          85.3, CH       110.4, C
  4          141.9, C       142.2, C       145.9, C       66.2, C           75.2, C        137.8, C
  5          124.0, CH      126.7, CH      125.5, CH      68.7, CH          89.3, CH       129.6, CH
  6          78.5, CH       76.8, CH       78.0, CH       82.7, CH          82.5, CH       76.4, CH
  7          52.2, CH       50.9, CH       52.1, CH       49.09, CH         48.0, CH       48.2, CH
  8          74.1, CH       74.0, CH       72.5, CH       73.3, CH          74.0, CH       71.5, CH
  9          46.8, CH~2~    126.8, CH      121.9, CH      49.15, CH~2~      49.3, CH~2~    42.9, CH~2~
  10         87.3, C        143.2, C       144.1, C       87.1, C           85.8, C        87.3, C
  11         139.0, C       140.1, C       140.0, C       137.2, C          137.1, C       137.7, C
  12         171.8, C       172.0, C       172.0, C       171.7, C          171.3, C       169.6, C
  13         124.8, CH~2~   121.8, CH~2~   121.8, CH~2~   127.0, CH~2~      125.5, CH~2~   123.8, CH~2~
  14         19.6, CH~3~    11.7, CH~3~    19.5, CH~3~    20.7, CH~3~       22.6, CH~3~    28.0, CH~3~
  15         20.2, CH~3~    22.8, CH~3~    23.6, CH~3~    20.5 ^b^, CH~3~   24.2, CH~3~    20.2, CH~3~
  1′         167.9, C       168.2, C       168.2, C       168.0, C          168.3, C       167.4, C
  2′         128.7, C       128.7, C       128.6, C       128.7, C          127.0, C       126.2, C
  3′         140.4, CH      139.9, CH      140.0, CH      14.03, CH         140.3, CH      139.4, CH
  4′         16.1, CH~3~    16.0, CH~3~    16.0, CH~3~    16.0, CH~3~       16.0, CH~3~    15.7, CH~3~
  5′         20.7, CH~3~    20.8, CH~3~    20.9, CH~3~    20.6 ^b^, CH~3~   20.5, CH~3~    20.6, CH~3~

^a^ Extracted from ^1^H-^13^C 2D inverse detected experiments due to low amount of sample; ^b^ interchangeable within the same column; ^c^ *p*-toluensulphonate group: C-1 (134.7), C-2/C-2′ (129.0), C-3/C-3′ (131.4), C-4 (147.2), -CH~3~ (21.6).
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###### 

^1^H-NMR spectroscopic data for compounds **13**--**16** (CD~3~OD; 500.13 MHz; δ in ppm).

  ---------------------------------------------------------------------------------------------------------------------------------------------
  Position        13 δ~H~ (mult, *J* in Hz)         14 δ~H~ (mult, *J* in Hz)          15 δ~H~ (mult, *J* in Hz)    16 δ~H~ (mult, *J* in Hz)
  --------------- --------------------------------- ---------------------------------- ---------------------------- ---------------------------
  1               4.11 (dd, 10.6, 6.5)              4.01 (dd, 11.7, 3.0)               \-                           \-

  2               1.91 ^a^\                         2.17 ^a^ (ddd, 15.0, 5.0, 3.0)\    6.65 (s)                     7.91 (d, 8.5)
                  2.43 (ddd, 15.5, 6.5, 6.0)        2.47 (ddd, 15.0, 11.7, 2.5)                                     

  3               5.49 (br d, 6.0)                  5.30 ^a^                           \-                           7.34 (br d, 8.5)

  4               \-                                \-                                 \-                           \-

  5               5.32 (dq, 8.5, 1.2)               5.32 (dq, 10.3, 1.2)               6.65 (s)                     7.58 (br s)

  6               5.28 ^a^                          5.87 (dd, 10.3, 2.0)               \-                           \-

  7               3.17 (dddd, 9.5, 8.5, 3.5, 3.0)   3.20 (dddd, 10.7, 2.0, 1.7, 1.5)   3.97 (d, 5.8)                \-

  8               5.65 (dd, 10.5, 9.5)              5.03 (td, 10.5, 4.0)               5.50 (ddd, 7.5, 5.7, 2.7)    7.19 (d, 7.2)

  9               5.24 (dq, 10.5, 1.2)              2.49 ^a^\                          1.80 ^a^\                    7.20 (d, 7.2)
                                                    2.90 (br dd, 13.6, 4.2)            2.00 (ddd, 13.0, 7.5, 6.0)   

  10              \-                                \-                                 3.97 (sextet, 7.0)           \-

  11              \-                                \-                                 \-                           \-

  12              \-                                \-                                 \-                           \-

  13              5.74 (d, 3.0)                     5.75 (d, 1.5)                      5.31 (br s)                  5.74 (d, 1.8)

  6.17 (d, 3.5)   6.23 (d, 1.7)                     6.33 (br s)                        6.51 (d, 1.8)                

  14              1.97 (d, 1.2)                     5.48 (br s)\                       1.34 (d, 7.0)                2.65 (s)
                                                    5.51 (br s)                                                     

  15              1.85 (d, 1.2)                     1.85 (d, 1.2)                      2.10 (s)                     2.46 (br s)

  1′              \-                                \-                                 \-                           \-

  2′              \-                                \-                                 \-                           \-

  3′              6.19 (qq, 7.0, 1.5)               6.15 (qq, 7.0, 1.5)                6.03 (qq, 7.0, 1.5)          \-

  4′              1.99 (dq, 7.0, 1.5)               1.96 (dq, 7.0, 1.5)                1.81 (dq, 7.0, 1.5)          \-

  5′              1.92 (quint, 1.5)                 1.90 (quint, 1.5)                  1.79 (quint, 1.5)            \-

  1″              \-                                \-                                 \-                           \-

  2″              2.02, (s)                         2.04, (s)                          \-                           \-
  ---------------------------------------------------------------------------------------------------------------------------------------------

^a^ Overlapped signals.
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###### 

^13^C-NMR spectroscopic data for compounds **13**--**16** (CD~3~OD; 125.77 MHz; δ in ppm).

  Position   13 δ~C~ ^a^    14 δ~C~ ^a^    15 ^a^ δ~C~    16 ^a^ δ~C~
  ---------- -------------- -------------- -------------- --------------
  1          75.4, CH       70.6, CH       140.5, C       132.5, C
  2          35.2, CH~2~    34.5, CH~2~    113.9, CH      125.0, CH
  3          74.6, CH       73.6, CH       155.0, C       128.4, CH
  4          137.9, C       139.4, C       124.0, C       136.4, C
  5          127.0, CH      124.8, CH      132.0, CH      126.1, CH
  6          76.0, CH       75.0, CH       126.6, C       128.6, CH
  7          50.0, CH       49.1, CH       48.3, CH       135.60, C
  8          72.8, CH       73.6, CH       71.9, CH       127.4, CH
  9          127.6, CH      39.8, CH~2~    33.6, CH~2~    126.0, CH
  10         141.7, C       144.4, C       31.5, CH       135.4, C
  11         139.0, C       135.2, C       145.1, C       145.5, C
  12         170.8, C       170.0, C       170.1, C       171.8, C
  13         121.3, CH~2~   125.7, CH~2~   129.1, CH~2~   127.6, CH~2~
  14         11.1, CH~3~    116.5, CH~2~   22.9, CH~3~    19.4, CH~3~
  15         22.2, CH~3~    21.7, CH~3~    15.6, CH~3~    21.7, CH~3~
  1′         167.6, C       166.8, C       169.4, C       \-
  2′         128.0, C       127.2, C       129.5, C       \-
  3′         139.5, CH      138.5, CH      138.8, CH      \-
  4′         15.6, CH~3~    14.6, CH~3~    15.4, CH~3~    \-
  5′         20.3, CH~3~    19.0, CH~3~    20.5, CH~3~    \-
  1″         169.2, C       170.0, C       \-             \-
  2″         20.9, CH~3~    19.7, CH~3~    \-             \-

^a^ Extracted from ^1^H-^13^C 2D inverse detected experiments due to low amount of sample.

molecules-22-02252-t005_Table 5

###### 

In vitro activity of compounds **1**, **3**--**8**, and **10**--**15** against *T. b. rhodesiense* (STIB 900), *T. cruzi* (Tulahuen C4 LacZ), *L. donovani* (MHOM-ET-67/L82), *P. falciparum* (NF54), and cytotoxicity in L6 cells.

  -----------------------------------------------------------------------------------------------------------------------------------------------
  Compound           *T. b. rhodesiense*\       *T. cruzi*\                *L. donovani*\            *P. falciparum*\          L6 cells\
                     IC~50~ (μM) ^a^            IC~50~ (μM) ^a^            IC~50~ (μM) ^a^           IC~50~ (μM) ^a^           IC~50~ (μM) ^a^
  ------------------ -------------------------- -------------------------- ------------------------- ------------------------- ------------------
  1                  2.08± 0.09 (2.4) ^b^       11.3± 3.3 (0.4) ^b^        2.69± 1.08 (1.8) ^b^      3.12± 0.52 (1.6) ^b^      4.91 ± 0.53

  3                  1.96± 0.16 (2.04) ^b^      4.24 (0.9) ^h^             13.19± 3.31 (0.3) ^b^     2.39 (1.7) ^h^            4.0 ± 0.03

  4                  2.18 ± 0.49 (2.6) ^b^      8.38 (0.7) ^h^             28.67 ± 8.95 (0.2) ^b^    3.20 (1.7) ^h^            5.56 ± 0.30

  5                  0.91 ± 0.16 (3.7) ^b^      6.35 (0.5) ^h^             8.28 ± 2.40 (0.4) ^b^     4.06 (0.8) ^h^            3.33 ± 0.28

  6--7               1.21 ± 0.16 (3.9) ^b^      16.00 ± 0.34 (0.3) ^b^     12.88 ± 0.65 (0.4) ^b^    13.82 ± 1.59 (0.3) ^b^    4.74 ± 0.24

  8                  3.25 ± 0.50 (3.5) ^b^      47.9 ± 1.11 (0.24) ^b^     66.8 ± 7.79 (0.17) ^b^    31.3 ± 2.40 (0.4) ^b^     11.5 ± 0.72

  10                 13.4 ± 0.46 (1.51) ^b^     132.19 ± 0.59 (0.15) ^b^   35.96 ± 0.18 (0.56) ^b^   79.13 ± 1.02 (0.26) ^b^   20.20 ± 2.098

  11                 1.57 ± 0.005 (0.28) ^b^    11.49 ± 0.68 (0.2) ^b^     4.20 ± 0.28 (0.55) ^b^    3.93 ± 0.53 (0.59) ^b^    2.31 ± 0.196

  12                 0.47 ± 0.006 (2.19) ^b^    2.60 ± 0.69 (0.5) ^b^      1.30 ± 0.03 (0.79) ^b^    1.55 ± 0.31 (0.66) ^b^    1.03 ± 0.076

  13                 0.54 ± 0.013 (3.46) ^b^    12.76 ± 1.08 (0.15) ^b^    3.26 ± 0.22 (0.57) ^b^    9.17 ± 0.61 (0.20) ^b^    1.87 ± 0.026

  14                 1.20 ± 0.151 (4.4) ^b^     15.4 ± 1.48 (0.6) ^b^      4.97 ± 0.43 (7.2) ^b^     8.80 ± 0.94 (0.68) ^b^    3.95 ± 0.088

  15                 13.32 ± 0.333 (1.68) ^b^   36.81 ± 7.76 (0.61) ^b^    5.86 ± 0.59 (3.83) ^b^    35.66 ± 1.10 (0.63) ^b^   22.44 ± 0.157

  Positive control   0.01 ± 0.01 ^c^            2.0 ± 0.2 ^d^              0.13 ± 0.01 ^e^           0.006 ± 0.01 ^f^          0.016 ± 0.01 ^g^
  -----------------------------------------------------------------------------------------------------------------------------------------------

^a^ Average of two independent assays in μg/mL; ^b^ Selectivity Index (SI): IC~50~ in L6 cells divided by IC~50~ in the titled parasitic strain; ^c^ melarsoprol; ^d^ benznidazole; ^e^ miltefosine; ^f^ chloroquine; ^g^ podophyllotoxin; ^h^ one assay.
